Search Results - "MURPHY, Robert L"

Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis by Musa, Jonah, Achenbach, Chad J, O'Dwyer, Linda C, Evans, Charlesnika T, McHugh, Megan, Hou, Lifang, Simon, Melissa A, Murphy, Robert L, Jordan, Neil

“…Although cervical cancer is largely preventable through screening, detection and treatment of precancerous abnormalities, it remains one of the top causes of…”
Get full text

Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study by Akanbi, Maxwell. O, Bilaver, Lucy. A, Achenbach, Chad, Hirschhorn, Lisa. R, Rivera, Adovich. S, Adekolujo, Orimisan. S, Adekola, Kehinde. U. A, Silas, Olugbenga. A, Agaba, Patricia. A, Agbaji, Oche, Shehu, Nathan. Y, Sagay, Solomon. A, Hou, Lifang, Murphy, Robert. L

“…Abstract Introduction The expansion of antiretroviral therapy (ART) eligibility could lead to earlier initiation of Human Immunodeficiency Virus (HIV)…”
Get full text

Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results by Sax, Paul E., Tierney, Camlin, Collier, Ann C., Daar, Eric S., Mollan, Katie, Budhathoki, Chakra, Godfrey, Catherine, Jahed, Nasreen C., Myers, Laurie, Katzenstein, David, Farajallah, Awny, Rooney, James F., Ha, Belinda, Woodward, William C., Feinberg, Judith, Tashima, Karen, Murphy, Robert L., Fischl, Margaret A.

“…Background. AIDS Clinical Trials Group A5202 compared blinded abacavir/lamivudine (ABC/3TC) to tenofovir DF/emtricitabine (TDF/FTC) with efavirenz (EFV) or…”
Get full text

The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials by Murphy, Robert L., Paramithiotis, Eustache, Sugden, Scott, Chermak, Todd, Lambert, Bruce, Montamat-Sicotte, Damien, Mattison, John, Steinhubl, Steve

“…First-generation anit-SARS-CoV-2 vaccines were highly successful. They rapidly met an unforeseen emergency need, saved millions of lives, and simultaneously…”
Get full text

Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): A point-of-care PCR test for rapid detection of SARS-CoV-2 infection by Achenbach, Chad J, Caputo, Matthew, Hawkins, Claudia, Balmert, Lauren C, Qi, Chao, Odorisio, Joseph, Dembele, Etienne, Jackson, Alema, Abbas, Hiba, Frediani, Jennifer K, Levy, Joshua M, Rebolledo, Paulina A, Kempker, Russell R, Esper, Annette M, Lam, Wilbur A, Martin, Greg S, Murphy, Robert L

“…An ideal test for COVID-19 would combine the sensitivity of laboratory-based PCR with the speed and ease of use of point-of-care (POC) or home-based rapid…”
Get full text

Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa-2a in HIV-1- Monoinfected Participants: A Phase II Clinical Trial by Asmuth, David M., Murphy, Robert L., Rosenkranz, Susan L., Lertora, Juan J. L., Kottilil, Shyam, Cramer, Yoninah, Chan, Ellen S., Schooley, Robert T., Rinaldo, Charles R., Thielman, Nathan, Li, Xiao-Dong, Wahl, Sharon M., Shore, Jessica, Janik, Jennifer, Lempicki, Richard A., Simpson, Yaa, Pollard, Richard B.

“…Background. To our knowledge, the antiviral activity of pegylated interferon alfa-2a has not been studied in participants with untreated human immunodeficiency…”
Get full text

Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali by Baya, Bocar, Achenbach, Chad J., Kone, Bourahima, Toloba, Yacouba, Dabitao, Djeneba K., Diarra, Bassirou, Goita, Drissa, Diabaté, Seydou, Maiga, Mamoudou, Soumare, Dianguina, Ouattara, Khadidia, Kanoute, Tenin, Berthe, Gaoussou, Kamia, Youssouf M., Sarro, Yeya dit Sadio, Sanogo, Moumine, Togo, Antieme C.G., Dembele, Bindongo P.P., Coulibaly, Nadie, Kone, Amadou, Akanbi, Maxwell, Belson, Michael, Dao, Sounkalo, Orsega, Susan, Siddiqui, Sophia, Doumbia, Seydou, Murphy, Robert L., Diallo, Souleymane

“…•MDR-TB was associated with younger age in Mali.•HIV was not a risk factor for MDR-TB.•MDR-TB did alter the patient’s physical condition compared to…”
Get full text

Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria by Magaji, F A, Mashor, M I, Anzaku, S A, Hinjari, A R, Cosmas, N T, Kwaghe, B V, Ali, J M, Christian, Elizabeth N, Sagay, A S, Chandler, Ariel, Khan, Imran, Murphy, Robert L, Hou, Lifang, Musa, J

“…High HIV prevalence, and lack of organized screening for the indigent population receiving care and treatment within HIV clinics in low-resource settings…”
Get full text

Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria by Musa, Jonah, Maiga, Mamoudou, Green, Stefan J, Magaji, Francis A, Maryam, Ali J, Okolo, Mark, Nyam, Chuwang J, Cosmas, Nanma T, Silas, Olugbenga A, Imade, Godwin E, Zheng, Yinan, Joyce, Brian T, Diakite, Brehima, Morhason-Bello, Imran, Achenbach, Chad J, Sagay, Atiene S, Ujah, Innocent A O, Murphy, Robert L, Hou, Lifang, Mehta, Supriya Dinesh

“…High risk human papillomaviruses (HR-HPV) have a causal role in cervical oncogenesis, and HIV-mediated immune suppression allows HR-HPV to persist. We studied…”
Get full text

Hepatocellular carcinoma presentation and prognosis among Nigerian adults with and without HIV by Davwar, Pantong M, Okeke, Edith, Duguru, Mary, Nyam, David, Bell, Kristen, Odeghe, Emuobor A, Oyeleke, Ganiat, Lesi, Olufunmilayo A, Singh, Revika, Kim, Kwang-Youn, Imade, Godwin, Akanmu, Alani S, Sagay, Atiene S, Ogunsola, Folasade T, Peters, Marion G, Roberts, Lewis R, Hou, Lifang, Murphy, Robert L, Hawkins, Claudia A

“…Hepatocellular carcinoma (HCC) is an increasing cause of mortality in Nigeria among persons with HIV (PLH), as access to antiretroviral therapy (ART) improves…”
Get full text

Integrated antibody and cellular immunity monitoring are required for assessment of the long term protection that will be essential for effective next generation vaccine development by Paramithiotis, Eustache, Varaklis, Christophe, Pillet, Stephane, Shafiani, Shahin, Lancelotta, Mary Pat, Steinhubl, Steve, Sugden, Scott, Clutter, Matt, Montamat-Sicotte, Damien, Chermak, Todd, Crawford, Stephanie Y, Lambert, Bruce L, Mattison, John, Murphy, Robert L

“…The COVID pandemic exposed the critical role T cells play in initial immunity, the establishment and maintenance of long term protection, and of durable…”
Get full text

p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies by Diakite, Brehima, Kassogue, Yaya, Dolo, Guimogo, Wang, Jun, Neuschler, Erin, Kassogue, Oumar, Keita, Mamadou L, Traore, Cheick B, Kamate, Bakarou, Dembele, Etienne, Nadifi, Sellama, Murphy, Robert L, Doumbia, Seydou, Hou, Lifang, Maiga, Mamoudou

“…The effect of the p.Arg72Pro variant of the P53 gene on the risk of development ofbreast cancer remains variable in populations. However, the use ofstrategies…”
Get full text

Mycobacterium africanum (Lineage 6) shows slower sputum smear conversion on tuberculosis treatment than Mycobacterium tuberculosis (Lineage 4) in Bamako, Mali by Diarra, Bassirou, Kone, Mahamadou, Togo, Antieme Combo Georges, Sarro, Yeya Dit Sadio, Cisse, Aissata Boubakar, Somboro, Amadou, Degoga, Boureima, Tolofoudie, Mohamed, Kone, Bourahima, Sanogo, Moumine, Baya, Bocar, Kodio, Ousmane, Maiga, Mamoudou, Belson, Michael, Orsega, Susan, Krit, Meryam, Dao, Sounkalo, Maiga, Ibrahim Izétiegouma, Murphy, Robert L, Rigouts, Leen, Doumbia, Seydou, Diallo, Souleymane, de Jong, Bouke Catherine

“…Ancestral M. tuberculosis complex lineages such as M. africanum are underrepresented among retreatment patients and those with drug resistance. To test the…”
Get full text

Development and clinical evaluation of a new multiplex PCR assay for a simultaneous diagnosis of tuberculous and nontuberculous mycobacteria by Sarro, Yeya dit Sadio, Butzler, Matthew A., Sanogo, Fanta, Kodio, Ousmane, Tolofoudie, Mohamed, Goumane, Mariam S., Baya, Bocar, Diabate, Seydou, Diallo, Ibrahim Boubacar, Daniogo, Djakaridja, Dembele, Bindongo P.P., Camara, Issiaka, Kumar, Alisha, Dembele, Etienne, Kone, Bourahima, Achenbach, Chad J., Theron, Grant, Ouattara, Khadidia, Toloba, Yacouba, Diarra, Bassirou, Doumbia, Seydou, Taiwo, Babafemi, Holl, Jane L., Murphy, Robert L., Diallo, Souleymane, McFall, Sally M., Maiga, Mamoudou

“…The prevalence of non-tuberculous mycobacteria (NTM) has been increasing worldwide in both developed and developing countries. NTM infection is clinically…”
Get full text

Achieving a robust mentoring and research capacity program in a LMIC - the BRAINS faculty development model by Ogunsola, Folasade Tolulope, Sekoni, Adekemi, Akanmu, Alani Sulaimon, Adeyemo, Wasiu Lanre, Osuntoki, Akinniyi, Manga-Atangana, Bibiane, Afolabi, Bosede Bukola, Okubadejo, Njideka Ulunma, Emmanuel, Madonna, Caleb-Adepoju, Sikeade Olawumi, Folarin, Olalekan, Okonkwo, Prosper, Murphy, Robert L, Kanki, Phyllis

“…A research and training program (RTP) was carried out to build the capacity of faculty and improve the culture of research in the College of Medicine,…”
Get full text

Has Omicron Changed the Evolution of the Pandemic? by Lundberg, Alexander L, Lorenzo-Redondo, Ramon, Ozer, Egon A, Hawkins, Claudia A, Hultquist, Judd F, Welch, Sarah B, Prasad, P V Vara, Oehmke, James F, Achenbach, Chad J, Murphy, Robert L, White, Janine I, Havey, Robert J, Post, Lori Ann

“…Variants of the SARS-CoV-2 virus carry differential risks to public health. The Omicron (B.1.1.529) variant, first identified in Botswana on November 11, 2021,…”
Get full text

Antituberculosis Therapy and Gut Microbiota: Review of Potential Host Microbiota Directed-Therapies by Diallo, Dramane, Somboro, Anou M, Diabate, Seydou, Baya, Bacar, Kone, Amadou, Sarro, Yeya S, Kone, Bourahima, Diarra, Bassirou, Diallo, Souleymane, Diakite, Mahamadou, Doumbia, Seydou, Toloba, Yacouba, Murphy, Robert L, Maiga, Mamoudou

“…Tuberculosis (TB) remains a major public health concern with millions of deaths every year. The overlap with HIV infections, long treatment duration, and the…”
Get full text

Molecular epidemiology and genetic diversity of Mycobacterium tuberculosis complex in referral health centers of Bamako, Mali: What is new? by Kone, Bourahima, Somboro, Anou M., Kone, Mahamadou, Holl, Jane L., Baya, Bocar, Dabitao, Djeneba, Diallo, Dramane, Diarra, Bassirou, Kone, Amadou, Sarro, Yeya Dit Sadio, Sanogo, Moumine, Togo, Antieme CG, Murphy, Robert L., Diallo, Souleymane, Coulibaly, Nadie, Camara, Fatoumata, Samake, Seydou, Diakite, Mahamadou, Doumbia, Seydou, Maiga, Mamoudou

“…Tuberculosis (TB) remains an important global health issue worldwide. Despite this scourge threatening many human lives, especially in developing countries,…”
Get full text

DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma by Zheng, Yinan, Hlady, Ryan A, Joyce, Brian T, Robertson, Keith D, He, Chunyan, Nannini, Drew R, Kibbe, Warren A, Achenbach, Chad J, Murphy, Robert L, Roberts, Lewis R, Hou, Lifang

“…The two most common repetitive elements (REs) in humans, long interspersed nuclear element-1 (LINE-1) and Alu element (Alu), have been linked to various…”
Get full text

Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children by Fofana, Djeneba B, Diarra, Houdou, Guindo, Ibrahima, Savadogo, Mahamadou K, d'Almeida, Marceline, Diallo, Fatoumata I, Baldé, Aliou, Soulié, Cathia, Kone, Amadou, Marcelin, Anne-Geneviève, Maiga, Almoustapha I, Lambert-Niclot, Sidonie, Maiga, Mamoudou, McFall, Sally, Hawkins, Claudia A, Murphy, Robert L, Sylla, Mariam, Katlama, Christine, Holl, Jane L, Calvez, Vincent, Morand-Joubert, Laurence

“…Integrase inhibitors (INIs) are a potent option for HIV treatment. Limited data exist on INI resistance in West Africa, particularly in children living with…”
Get full text